Immunitybio Inc IBRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
4.45quote price arrow up+0.12 (+2.77%)
Volume
34,003
Close
4.33quote price arrow down-0.12 (-2.70%)
Volume
1,886,251
52 week range
2.60 - 7.85
Loading...
  • Open4.36
  • Day High4.59
  • Day Low4.25
  • Prev Close4.45
  • 52 Week High7.85
  • 52 Week High Date02/17/22
  • 52 Week Low2.60
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.733B
  • Shares Out400.30M
  • 10 Day Average Volume1.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-14.6

KEY STATS

  • Open4.36
  • Day High4.59
  • Day Low4.25
  • Prev Close4.45
  • 52 Week High7.85
  • 52 Week High Date02/17/22
  • 52 Week Low2.60
  • 52 Week Low Date05/12/22
  • Market Cap1.733B
  • Shares Out400.30M
  • 10 Day Average Volume1.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-14.6

RATIOS/PROFITABILITY

  • EPS (TTM)-1.00
  • P/E (TTM)-4.32
  • Fwd P/E (NTM)-4.20
  • EBITDA (TTM)-328.272M
  • ROE (TTM)-3,787.09%
  • Revenue (TTM)556,999.981
  • Gross Margin (TTM)-
  • Net Margin (TTM)-71,911.49%
  • Debt To Equity (MRQ)-156.23%

EVENTS

  • Earnings Date03/10/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunitybio Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Immunitybio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapies and vaccines that improve the immune system to defeat cancers and infectious diseases. Its immunotherapy and cell therapy platforms include antibody cytokine fusion proteins; synthetic immunomodulators; vaccine technologies, which includes human adenovirus (hAd5) viral vector, and genetically modified off-the-shelf natural killer cells (NK cells), which activate both...
Patrick Soon-Shiong M.D.
Executive Chairman of the Board, Global Chief Scientific and Medical Officer
Richard Adcock
President, Chief Executive Officer, Director
David Sachs
Chief Financial Officer
Address
3530 John Hopkins Ct
San Diego, CA
92121-1121
United States

Top Peers

SYMBOLLASTCHG%CHG
RETA
Reata Pharmaceuticals Inc
48.87-0.63-1.27%
AGIO
Agios Pharmaceuticals Inc
30.20+0.02+0.07%
RYTM
Rhythm Pharmaceuticals Inc
28.63-0.27-0.93%
RCKT
Rocket Pharmaceuticals Inc
20.52-1.43-6.51%
ACLX
Arcellx Inc
32.70-0.67-2.01%